Rockefeller Capital Management L.P. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 324 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$418,577
-31.1%
15,873
-20.6%
0.00%
-50.0%
Q1 2024$607,490
-96.9%
20,002
-97.1%
0.00%
-96.9%
Q4 2023$19,465,377
+2373.1%
692,964
+2289.4%
0.06%
+2066.7%
Q3 2023$787,091
+2.2%
29,001
+15.7%
0.00%0.0%
Q2 2023$770,402
+85882.4%
25,061
+0.7%
0.00%
-25.0%
Q1 2023$896
-75.9%
24,890
-73.5%
0.00%
-78.9%
Q4 2022$3,715
-99.9%
94,003
-9.0%
0.02%
-9.5%
Q3 2022$4,149,000
-1.2%
103,260
+3.4%
0.02%
-4.5%
Q2 2022$4,199,000
+7.7%
99,887
-0.2%
0.02%
+15.8%
Q1 2022$3,900,000
-22.7%
100,106
-20.9%
0.02%
-20.8%
Q4 2021$5,045,000
+70.6%
126,623
+54.7%
0.02%
+50.0%
Q3 2021$2,957,000
+363.5%
81,826
+425.3%
0.02%
+300.0%
Q2 2021$638,000
+17.1%
15,576
+24.6%
0.00%0.0%
Q1 2021$545,000
-21.4%
12,504
-9.8%
0.00%
-20.0%
Q4 2020$693,000
+264.7%
13,863
+206.4%
0.01%
+150.0%
Q3 2020$190,000
+95.9%
4,524
+126.2%
0.00%
+100.0%
Q2 2020$97,0002,0000.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$263,446,00059.92%
Memorial Sloan Kettering Cancer Center 1,128,255$43,957,00050.90%
Vantage Consulting Group Inc 2,727,854$106,277,00041.47%
Indie Asset Partners, LLC 756,874$29,488,00022.15%
Overbrook Management Corp 723,250$28,178,0006.25%
Brown University 621,759$24,224,0005.93%
Geo Capital Gestora de Recursos Ltd 200,692$8,527,0003.82%
Lagoda Investment Management, L.P. 141,560$5,515,0002.97%
Greytown Advisors Inc. 131,143$5,109,0002.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,025,610$78,918,0002.41%
View complete list of ROYALTY PHARMA PLC shareholders